PROTRACTED ACTIVITY ORAL HYDROGEL BEAD
First Claim
Patent Images
2. The carriers according to claim 1 wherein said particles comprise a core consisting of said beads as a macroporous hydrogel containing the saturated biologically active oral therapeutic substance, and an outer inert acid resistant coating layer, said carriers intended for treating diseases of the gastro-intestinal tract.
0 Assignments
0 Petitions
Accused Products
Abstract
Drugs are released gradually to a living organism after oral ingestion, through a layer of non-ionogenic, neutral hydrogel of a polymer of ethylene glycol methacrylate or similar monomer cross-linked sufficiently to make the polymer insoluble in all gastro intestinal liquids.
26 Citations
5 Claims
-
2. The carriers according to claim 1 wherein said particles comprise a core consisting of said beads as a macroporous hydrogel containing the saturated biologically active oral therapeutic substance, and an outer inert acid resistant coating layer, said carriers intended for treating diseases of the gastro-intestinal tract.
-
3. The carrier according to claim 1 wherein said thickness and diffusion rates are predetermined and predefined to provide a controlled delivery for tetracyline hydrochloride from each particle.
-
4. The carrier according to claim 3 wherein said tetracyline hydrochloride as the biological substance comprises about 1 percent of said mixture.
-
5. The carrier according to claim 1 wherein said mixture comprises fractions of one part 0.1 - 0.5 parts of 0.5 - 1 mm and three parts of 1 - 2 mm beads prepared in bead form 0.1 -2.0 mm in size.
Specification